Answer
Women of reproductive potential should use effective contraception throughout abrocitinib (Cibinqo) treatment and for 1 month after the final dose.
Sources for this answer
- Cibinqo 200 mg film-coated tabletsPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 14Document updated
Sources checked